[Optimization of chemotherapy of stomach cancer]

Results are analyzed of the treatment of 520 patients with diffuse gastric cancer using different schemes that included chemotherapy with fluorouracil, intraabdominal polychemotherapy with fluorouracil and adriablastin, immunotherapy with yeast polysaccharides and thymus hormone--taktivin. Chemotherapy supplemented by immunotherapy essentially increases survival. Intraabdominal administration of antitumour drugs in gastric cancer is anatomically more adequate than the intravenous route.